Addition to network recognizes specialized care in neurofibromatosis and schwannomatosis
- First nationwide network to help those with genetic condition
- Cancer center one of eight new additions to network
- Network includes only 80 clinics across U.S. and Canada
BUFFALO, N.Y. — Roswell Park Comprehensive Cancer Center is proud to announce the recent addition of its Adult Multidisciplinary Neurofibromatosis Clinic to the NF Clinic Network, an initiative of the Children’s Tumor Foundation dedicated to providing high-quality patient-centered care for individuals living with neurofibromatosis or schwannomatosis. The network now includes nearly 80 clinics across the United States and Canada.
NF is a group of genetic conditions that leads to the development of nerve tissue tumors in several body areas. These tumors can press on nerves and other tissues, resulting in pain, scoliosis of the spine, learning disabilities, vision and hearing loss and extensive skin growths.
While most tumors are noncancerous, some become malignant and the condition increases risk for other types of cancers such as breast and pheochromocytoma, a rare cancer of the adrenal gland. Lifelong monitoring, early cancer detection and timely treatment is essential for optimal survival and quality of life.
Roswell Park is one of eight new clinics added to the NFCN – the first nationwide network dedicated to improving clinical care and establishing best practices for treating those living with NF.
“Joining the NF Clinic Network is an important milestone for our team and, most importantly, for the patients we serve,” says Lindsay Lipinski, MD, MSc, FAANS, FACS, HEC-C of Roswell Park. “This designation recognizes the strength of our multidisciplinary care and enhances our ability to collaborate nationally and internationally, ensuring patients with neurofibromatosis and schwannomatosis receive the highest quality, most coordinated care possible.”
As part of the NF Clinic Network, Roswell Park has earned NF1 Specialty and SWN Specialty designations, reflecting the clinic’s adherence to rigorous standards for evidence-based NF management, research engagement and patient education.
Roswell Park’s NF clinic provides experienced radiologists, comprehensive clinical care, supportive care services, cancer screening and surveillance and access to the latest treatments through participation in clinical trials.
###
From the world’s first chemotherapy research to the PSA prostate cancer biomarker, Roswell Park Comprehensive Cancer Center generates innovations that shape how cancer is detected, treated and prevented worldwide. The Roswell Park team of 4,000+ makes compassionate, patient-centered cancer care and services accessible across New York State and beyond. Rated “Exceptional” by the National Cancer Institute, Roswell Park, founded in 1898, was one of the first NCI-designated comprehensive cancer centers in the country and remains the only one in Upstate New York. To learn more about Roswell Park Comprehensive Cancer Center and the Roswell Park Care Network, visit www.roswellpark.org, call 1-800-ROSWELL (1-800-767-9355) or email ASKRoswell@RoswellPark.org.
About the Children’s Tumor Foundation
The Children’s Tumor Foundation (CTF) drives the discovery and development of treatments for NF. As the drug discovery engine for neurofibromatosis and schwannomatosis—genetic conditions affecting 1 in 2,000 births that cause tumors to grow on nerves throughout the body—we connect patients, clinicians, researchers and industry to accelerate drug development, advance care and move closer to cures. Established in 2007, the NF Clinic Network (NFCN) is a CTF program, and the first nationwide network dedicated to improving clinical care and establishing best practices for people living with NF, with more than 80 recognized clinics across the United States and Canada. Learn more at ctf.org/doctor.
Jane Rose, Media Relations Specialist
716-845-4919; jane.rose@roswellpark.org